Botalys is a Belgian pioneer in hydroponic precision farming, using a controlled-environment platform to reproduce ideal growth conditions for rare medicinal plants. Its technology produces 100% pure, clinically ultra-premium botanicals aimed at the nutraceutical and cosmetic markets while preserving plants' natural biotopes. The company operates a factory and an R&D center in Ghislenghien dedicated to developing new plants and innovative derivatives. Botalys aims to deploy its platform across additional medicinal plants and to expand commercially in American and Asian markets. It seeks to become the largest vertical farm in Belgium and a global leader in rare medicinal-plant cultivation. Prior public backing and grants have supported its industrial development and R&D efforts.

Total raised

$7M

Funding rounds

1

Latest round

Series B

Latest activity

Oct 2022